Market by Deployment Mode, Component, Product Type, End-user, and Country | Forecast 2021-2028
Triton’s report expects the Latin America clinical trial management market to advance at a CAGR of 9.05% during the estimated phase 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in this market include:
• Brazil
• Mexico
• Rest of Latin America
The
Latin America region is projected to experience growth in the upcoming years,
owing to a rise in the adoption of novel drugs, advancement in clinical
research, and availability of a large patient population. Moreover, the use of
advanced technology is another factor motivating the progression of the
clinical trial management market across the region.
Among
the region’s nations, Brazil has the largest population base, with over 200
inhabitants. Moreover, it is among the ten largest pharmaceutical markets
globally where a qualified workforce upholds regulatory compliance to clinical
trials. Here, the regulatory process to obtain approval for clinical trials
takes longer, exceeding 12 or 18 months. This has forced trials to start later
than in other countries. The longer duration resulted in the release of new
rules and timelines by ANVISA, stating that upon receipt of the Drug Clinical
Development Dossier, ANVISA has 90 days to evaluate. Thus, these factors
indicate a scope of improvement for clinical trials in the country, opening new
opportunities for the clinical trial management market in Brazil.
After
Brazil, Mexico stands to be the second-largest pharmaceutical market in the
region. Here, the pharmaceutical industry contributes significantly to the
country’s economy. Additionally, the country’s health system provides a wide
range of clinical research alternatives in private and public sectors, where
health services are diversified on a large scale. Therefore, the pharma
industry’s positive growth is expected to widen the scope and development of
the clinical trial management market across Mexico.
Oracle
Corporation is among the leading companies providing products and services for
corporate information technology environments, such as application, platform,
and infrastructure. Its business segments include hardware systems, software,
and cloud services. Among the wide product portfolio, Oracle’s clinical unified
platform is a single cloud environment that is flexible, bringing features
required for a specific trial. Also, its software is designed to operate on
single and multi-service configurations. Oracle has operations in various
regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
SCOPE
2.2. KEY
INSIGHTS
2.2.1. ENTERPRISE-BASED
CTM CONTRIBUTES A MAJOR SHARE IN PRODUCT TYPE SEGMENT
2.2.2. HEALTHCARE
PROVIDERS ARE RAPIDLY GROWING END-USERS IN THE MARKET
2.2.3. SOFTWARE
IS THE LARGEST COMPONENT IN THE CLINICAL TRIAL MANAGEMENT MARKET
2.2.4. CLOUD
MODEL OF DEPLOYMENT IS A PROMISING SEGMENT IN THE MARKET
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. INTENSITY
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. MARKET
DRIVERS
2.6.1. ALARMING
RISE IN CHRONIC DISEASES
2.6.2. SURGE
IN RESEARCH & DEVELOPMENT IN THE MEDICAL SECTOR
2.6.3. BENEFITS
OFFERED BY CTM SOFTWARE
2.7. MARKET
RESTRAINTS
2.7.1. CONCERN
REGARDING THE SECURITY OF CTM SYSTEMS
2.7.2. LACK
OF SKILLED WORKFORCE
2.7.3. HIGH
COST OF IMPLEMENTATION
2.8. MARKET
OPPORTUNITIES
2.8.1. GROWTH
IN CLINICAL TRIALS
2.8.2. OUTSOURCING
CLINICAL TRIALS FOR COST REDUCTION
2.9. KEY
STRATEGIC DEVELOPMENTS
2.9.1. MERGER
& ACQUISITIONS
2.9.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.9.3. PARTNERSHIP,
CONTRACT/AGREEMENT, & COLLABORATION
2.10. IMPACT
OF COVID-19 ON THE CLINICAL TRIAL MANAGEMENT MARKET
3. LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY DEPLOYMENT MODE
3.1. WEB-BASED
DEPLOYMENT
3.2. ON-PREMISE
DEPLOYMENT
3.3. CLOUD-BASED
DEPLOYMENT
4. LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY COMPONENT
4.1. SOFTWARE
4.2. HARDWARE
4.3. SERVICES
5. LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY PRODUCT TYPE
5.1. ENTERPRISE-BASED
CTM
5.2. SITE-BASED
CTM
6. LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET OUTLOOK - BY END-USER
6.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
6.2. CLINICAL
RESEARCH ORGANIZATIONS
6.3. HEALTHCARE
PROVIDERS
7. CLINICAL
TRIAL MANAGEMENT MARKET – LATIN AMERICA
7.1. BRAZIL
7.2. MEXICO
7.3. REST
OF LATIN AMERICA
8. COMPETITIVE
LANDSCAPE
8.1. MEDIDATA
SOLUTIONS INC
8.2. ARISGLOBAL
LLC
8.3. BIOCLINICA
INC
8.4. BIO-OPTRONICS
INC
8.5. ADVARRA
(FORTE RESEARCH SYSTEMS INC)
8.6. ORACLE
CORPORATION
8.7. IBM
CORPORATION
8.8. MEDNET
SOLUTIONS INC
8.9. PAREXEL
INTERNATIONAL CORPORATION
8.10. VEEVA
SYSTEMS INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR
SCORECARD
TABLE 3: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2021-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2020 & 2028 (IN %)
FIGURE 2: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 3: MARKET
ATTRACTIVENESS INDEX
FIGURE 4: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 5: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 6: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $
MILLION)
FIGURE 7: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA
CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028
(IN $ MILLION)
FIGURE 11: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $
MILLION)
FIGURE 12: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL &
BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS,
2021-2028 (IN $ MILLION)
FIGURE 14: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028
(IN $ MILLION)
FIGURE 15: LATIN
AMERICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN
%)
FIGURE 16: BRAZIL
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 17: MEXICO
CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 18: REST OF
LATIN AMERICA CLINICAL TRIAL MANAGEMENT MARKET 2021-2028 (IN $ MILLION)